ARTICLE | Clinical News
Kyprolis carfilzomib regulatory update
October 5, 2015 7:00 AM UTC
EMA’s CHMP recommended approval of Kyprolis carfilzomib from Amgen in combination with lenalidomide and dexamethasone to treat multiple myeloma (MM) in adults who have received >=1 prior therapy. The ...